Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia
Jessica K. Altman; James M. Foran; Keith W. Pratz; Denise Trone; Jorge E. Cortes; Martin S. Tallman
Author Information: Robert H. Lurie Comprehensive Cancer Center, Northwestern University
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.